TFF Pharmaceuticals CEO On Vaccines In Dry Powder Form

Schwab Network

English - January 15, 2021 19:29 - 6 minutes - 30.1 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Next Stage Of Cryptocurrency

Next Episode: Asset Allocation For Young Investors

The President and CEO of TFF Pharmaceuticals (TFFP), Glenn Mattes, says that the company has the capability to reformulate vaccines and other drugs into dry powder form which can increase shelf life.